Cite

1. Berbec N, Papuc S, Tutulan-Cunita A, Angelescu S, Lupu A, Arghir A. Molecular characterization of complex chromosomal change in de novo acute myeloid leukemia; a case report. Rev Romana Med Lab. 2013;21(1):59-65. DOI: 10.2478/rrlm-2013-001810.2478/rrlm-2013-0018Search in Google Scholar

2. Falini B, Mecucci C, Tiacci E, Alcalav M, Rosati R, Pasqualucci L et al.; GIMEMA Acute Leukemia Working Party. Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype [published correction appears in N Engl J Med. 2005;352:740]. N Engl J Med. 2005 Jan;352(3):254-66. DOI: 10.1056/ NEJMoa041974Search in Google Scholar

3. Kroschinsky FP, Schäkel U, Fischer R, Mohr B, Oelschlaegel U, Repp R et al., for the DSIL (Deutsche Studieninitiative Leukämien) Study Group. Cuplike acute myeloid leukemia: new disease or artificial phenomenon? Haematologica. 2008 Feb;93(2):283-6. DOI: 10.3324/haematol.1166910.3324/haematol.1166918223289Search in Google Scholar

4. Chen W, Rassidakis GZ, Li j, Routbort M, Jones D, Kantarjian H et al. High frequency of NPM1 gene mutations in acute myeloid leukemia with proeminent nuclear invaginations(„cuplike nuclei”). Blood. 2006 Sep;108(5):1783-4. DOI: 10.1182/ blood-2006-03-01434010.1182/blood-2006-03-01434016926303Search in Google Scholar

5. Park BG, Chi HS, Jung S, Park CJ, Kim DY, Lee JH et al. Association of cup-like nuclei in blasts with FLT3 and NPM1 mutation in acute myeloid leukemia. Ann Hematol. 2013 Apr;92(4):451-7. DOI: 10.1007/ s00277-012-1645-510.1007/s00277-012-1645-523238897Search in Google Scholar

6. Vardiman J, Thiele J, Arber D, Brunning R, Borowitz M, PorwitA et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and importantchanges. Blood. 2009;114(5):937-51. DOI: 10.1182/ blood-2009-03-20926210.1182/blood-2009-03-20926219357394Search in Google Scholar

7. Schnittger S, Schoch C, Kern W, Mecucci C, Tschulik C, Martelli MF, et al. Nucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with a normal karyotype. Blood. 2005 Dec;106(12):3733-9. DOI: 10.1182/ blood-2005-06-224810.1182/blood-2005-06-224816076867Search in Google Scholar

8. Verhaak RG, Goudswaard CS, van Putten W, Bijl MA, Sanders MA, Hugens W et al. Mutations in nucleophosmin (NPM1) in acute myeloid leukemia (AML): association with other gene abnormalities and previously established gene expression signatures and their favorable prognostic significance. Blood. 2005 Dec;106(12):3747-54. DOI: 10.1182/ blood-2005-05-2168 9 Thiede C, Koch S, Creutzig E, Steudel C, Illmer T, Schaich M et al. Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML). Blood. 2006 May;107(10):4011-20. DOI: 10.1182/blood-2005-08-3167 10.1182/blood-2005-08-316716455956Search in Google Scholar

eISSN:
2284-5623
Language:
English
Publication timeframe:
4 times per year
Journal Subjects:
Life Sciences, Molecular Biology, Biochemistry, Human Biology, Microbiology and Virology